Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies-Reference-Cited by-同舟云学术

Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies

Published:2009-06 Issue:2 Volume:74 Page:433-439
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Kubicek Gregory J.,Werner-Wasik Maria,Machtay Mitchell,Mallon Gayle,Myers Thomas,Ramirez Michael,Andrews David,Curran Walter J.,Dicker Adam P.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Brain tumors;DeAngelis;N Engl J Med,2001

2. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial;Walker;J Neurosurg,1978

3. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma;Green;Cancer Treat Rep,1983

4. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas: A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study;Chang;Cancer,1983

5. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma: Brain Tumor Cooperative Group trial 8001;Shapiro;J Neurosurg,1989

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteasome Inhibitors against Glioblastoma—Overview of Molecular Mechanisms of Cytotoxicity, Progress in Clinical Trials, and Perspective for Use in Personalized Medicine;Current Oncology;2023-11-02

2. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies;International Journal of Molecular Sciences;2023-06-21

3. Bortezomib abrogates temozolomide-induced autophagic flux through an ATG5 dependent pathway;Frontiers in Cell and Developmental Biology;2022-12-22

4. Nutzen der Radioonkologie beim solitären Plasmozytom oder multiplen Myelom;Der Radiologe;2021-11-11

5. Overcoming TRAIL Resistance for Glioblastoma Treatment;Biomolecules;2021-04-14